Data / Form D filings / Biolog, Inc. /DE/
Biolog, Inc. /DE/: Form D filings
Biolog, Inc. /DE/, a biotechnology company in Hayward, CA, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on February 19, 2025, reports $16.1 million sold of a $17.1 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21124 CABOT BLVD., Hayward, CA, 94545
- Phone
- (510) 785-2564
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1940250
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | New notice | $17,122,980 | $16,122,991 | $999,989 | 22 | Feb 10, 2025 | sec.gov |
| Feb 6, 2023 | Amendment | $17,500,000 | $17,500,000 | 20 | Apr 28, 2022 | sec.gov | |
| Jul 28, 2022 | New notice | $10,000,000 | $10,000,000 | 19 | Apr 28, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tim Harkness | Director | |
| William Snider | Director | |
| Robert Wicke | Executive Officer, Director | |
| Chad Souvignier | Director | |
| Anne Rogove Stone | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biolog, Inc. /DE/ reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.